• Facebook
  • Twitter
  • Wiki

Karolinska Institutet

Selected publications of the Department of Oncology-Pathology from 2010.


Linderholm BK, Hellborg H, Johansson U, Skoog L, Lehtiö J. Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer. Breast Cancer Res Treat. 2010 Nov 26

Rosenberg LH, Franzén B, Auer G, Lehtiö J, Forshed J. Multivariate meta-analysis of proteomics data from human prostate and colon tumours. BMC Bioinformatics. 2010 Sep 17;11:468

De Petris L, Brandén E, Herrmann R, Sanchez BC, Koyi H, Linderholm B, Lewensohn R, Linder S, Lehtiö J. Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer. Eur J Cancer. 2010 Sep 3. [Epub ahead of print]

Lengqvist J, Eriksson H, Gry M, Uhlén K, Björklund C, Bjellqvist B, Jakobsson PJ, Lehtiö J. Observed peptide pI and retention time shifts as a result of post-translational modifications in multidimensional separations using narrow-range IPG-IEF. Amino Acids. 2010 Aug 20. [Epub ahead of print]

Lehtiö J, De Petris L. Lung cancer proteomics, clinical and technological considerations. Journal of Proteomics, In Press,, Available online 1 June 2010

De Petris L, Pernemalm M, Elmberger G, Bergman P, Orre L, Lewensohn R, Lehtiö J.< A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants. Proteome Sci. 2010 Feb 26;8(1):9.

For more, see http://ki.se/ki/jsp/polopoly.jsp?d=35368&l=en